Type 2 diabetes, chronic kidney disease and major cardiovascular events in patients with established coronary artery disease

被引:0
|
作者
Sprenger, L. [1 ]
Vonbank, A. [2 ]
Larcher, B. [2 ]
Mader, A. [2 ]
Maechler, M. [1 ]
Mutschlechner, B. [1 ]
Benda, M. [1 ]
Leiherer, A. [3 ]
Muendlein, A. [1 ]
Drexel, H. [4 ]
Saely, C. H. [3 ]
机构
[1] VIVIT Inst, Feldkirch, Austria
[2] Acad Teaching Hosp Feldkirch, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Cty Hosp Bregenz, Bregenz, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1104 / 1104
页数:1
相关论文
共 50 条
  • [41] Type 2 diabetes and risk of major cardiovascular events in peripheral artery disease versus coronary artery disease patients
    Saely, C.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Sprenger, L.
    Mutschlechner, B.
    Benda, M.
    Muendlein, A.
    Leiherer, A.
    Drexel, H.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 345 - 346
  • [42] Type 2 Diabetes and Chronic Kidney Disease as Predictors of Cardiovascular Mortality in Patients with Established Cardiovascular Disease
    Sprenger, Lukas
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Plattner, Thomas
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2023, 72
  • [43] Type 2 Diabetes and Risk of Major Cardiovascular Events in Peripheral Artery Disease vs. Coronary Artery Disease Patients
    Saely, Christoph H.
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Sprenger, Lukas
    Mutschlechner, Beatrix
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2021, 70
  • [44] Serum resistin is associated with coronary artery disease and predicts major cardiovascular events in type 2 diabetes patients
    Menzaghi, C.
    Bacci, S.
    Salvemini, L.
    Powers, C.
    Fini, G.
    Rizza, S.
    Goheen, E.
    De Bonis, C.
    Kanagaki, A.
    Mangiacotti, D.
    Federici, M.
    Doria, A.
    Trischitta, V.
    DIABETOLOGIA, 2011, 54 : S58 - S58
  • [45] Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Klement, M.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S315 - S315
  • [46] Type 2 Diabetes and Risk of Cardiovascular Events in Peripheral Artery Disease versus Coronary Artery Disease Patients
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Klement, Margaretha
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    CIRCULATION, 2020, 142
  • [47] TYPE 2 DIABETES AND RISK OF CARDIOVASCULAR EVENTS IN PERIPHERAL ARTERY DISEASE VERSUS CORONARY ARTERY DISEASE PATIENTS
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Maechler, M.
    Mutschlechner, B.
    Klement, M.
    Zanolin-Purin, D.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    ATHEROSCLEROSIS, 2021, 331 : E199 - E199
  • [48] Type 2 diabetes and risk of cardiovascular events in peripheral artery disease versus coronary artery disease patients
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Klement, Margaretha
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S354 - S354
  • [49] Absence of Coronary Artery Disease is a Strong Negative Predictor of Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease
    Tonnesen, Pernille Tilma
    Olesen, Kevin Kris Warnakula
    Thrane, Pernille Gro
    Gyldenkerne, Christine
    Peters, Christian Daugaard
    Buus, Niels Henrik
    Maeng, Michael
    CLINICAL EPIDEMIOLOGY, 2023, 15 : 1109 - 1121
  • [50] Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
    Charytan, David M.
    Solomon, Scott D.
    Ivanovich, Peter
    Remuzzi, Giuseppe
    Cooper, Mark E.
    McGill, Janet B.
    Parving, Hans-Henrik
    Parfrey, Patrick
    Singh, Ajay K.
    Burdmann, Emmanuel A.
    Levey, Andrew S.
    Eckardt, Kai-Uwe
    McMurray, John J. V.
    Weinrauch, Larry A.
    Liu, Jiankang
    Claggett, Brian
    Lewis, Eldrin F.
    Pfeffer, Marc A.
    DIABETES OBESITY & METABOLISM, 2019, 21 (05): : 1199 - 1208